ロード中...
Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients with Atherosclerotic Renal Artery Stenosis
BACKGROUND: Atherosclerotic renal artery stenosis (ARAS) reduces renal blood flow (RBF) and amplifies stenotic kidney (SK) hypoxia. Revascularization with percutaneous transluminal renal angioplasty and stenting (PTRA) often fails to recover renal function possibly due to ischemia reperfusion injury...
保存先:
| 出版年: | Circ Cardiovasc Interv |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5659347/ https://ncbi.nlm.nih.gov/pubmed/28916603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCINTERVENTIONS.117.005487 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|